Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...

Chief of Naval Operations Adm. Lisa Franchetti was treated successfully for early-stage breast cancer this summer, the ...

Nearly half of women over 40 have dense breasts, which raises their risk of breast cancer. Mammograms should now include an ...

The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...

Researchers have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients. The findings show two distinct patterns of B cell ...

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach ...

FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...

During a Case-Based Roundtable® event, Ian Krop, MD, PhD, and event participants discussed how different types of metastases ...

Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative ...

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2 ...